Ive been involved in a few discussions lately about how pharma can improve compliance to their medications. Of course, this isnt the first time Ive had these discussions and, likely, it wont be the last. Part of my last job at AstraZeneca was managing our compliance program for their breast cancer products. If youre in pharma, you know that this debate has been going on for years. Within the last five years or so, interest has really picked up in this area likely because someone really started crunching the numbers. As pharma sales growth has slowed, theyve needed to look at different ways to sell more of their products. A seemingly obvious place to start is compliance. If you do some quick math, you figure out that if you can get people to stay on treatment, you can put hundreds of millions, if not billions, of dollars to the company bottom line. Seems simple enough
Somewhere around a third to a half (or more) of patients dont take their medications as prescribed. If you want to see a ton of stats about this covering a bunch of different diseases, check out the ultimate in compliance resources, AlignMap. Oh, and by the way, maybe youre thinking that those patients who are non-compliant are those with less serious diseases. Youre wrong. From AlignMap citing multiple sources
Thats a problem.
Its a problem weve tried to fix for a long, long time. And, weve tried a lot. Heres a list of the most common compliance interventions out there (again, credit to AlignMap, take the hint and check it out):
So, how many of these have you tried at your company? How many have made a big impact? The reality is that very few interventions make a significant difference in compliance rates. We havent figured out the magic bullet. If we had, we wouldnt still be having this conversation. For my part, I believe the reason we havent made an impact is because we test and use one intervention at a time. That is, you create a text message reminder program to improve compliance. But what if I dont use text messages? What we need to offer is a wide choice of different compliance programs with each individual enrolled in the programs that are going to impact them. Of course, this might not be completely practical, as it would require you to create twenty (or more) different compliance programs (see the above list) so that each person had enough choice. That could get pricey. Sorry to say, but likely thats whats going to be the thing that significantly impacts compliance when the first company decides to take the plunge and create a comprehensive platform like this.
In the meantime, lets look at something different. Lets try something not on the listsomething that hasnt been done before. Its called fun.
Perhaps youve heard of it (from Merriam-Webster).
FUN, Pronunciation: \?f?n\, Function: noun
Etymology: English dial. fun to hoax, perhaps alteration of Middle English fonnen, from fonne dupe
1 : what provides amusement or enjoyment; specifically : playful often boisterous action or speech <full of fun>
Okay, glad I could remind you. Fun. You like fun, right? Not much from that list above appears to be fun. So, what does fun have to do with drug compliance?
Watch what fun can do
Now, if the pharma industry (myself included perhaps) was asked to increase the number of people who chose the stairs, wed probably do it a little differently. Likely, wed put up some signs that show the benefits of exercise on cardiovascular disease (and you know wed use the word cardiovascular a lot). Wed also probably tell you about the risk of not getting enough exercise. Maybe wed even get a celebrity that we could put on the signs (or make cutouts)Im thinking one of those trainers from The Biggest Loser would be great. And, wed probably put in some sort of flashing light to call attention to the people who decided not to take the stairs.
Ho hum. All of those things have one thing in commonthey arent very fun.
I was recently at a great meeting (in Iceland) where I met people from many different industries. One of the people I spent a lot of time with was Toby Barnes who is Managing Director for a company called Mudlark. This company does a lot, but in the end, theyre a company that makes games. Toby has incredible passion about gaming, but hes not the guy who sits in front of the XBOX all day. He simply believes in the power of games to change behavior. Toby really just wants to create fun. One of the many things he told me that stuck with me was really simple. Im going to paraphrase, but the gist was this: humans learn by playing. From the moment were born, through our most important developmental years, we learn by playing. The roles we play in life, how things work, whats good and bad behavior, and how to communicate with othersall from playing. Somewhere along the way though, we stop playing and stop learning.
So, what is playing? Well, first, playing is supposed to be fun. Without that, the rest doesnt matter much since no one will play with something that isnt fun.
Lets go back to the Volkswagon video. They created something fun, something people played with. People saw that taking the stairs could not only be fun, but also that it wouldnt kill them to do so from time to time. We all know that we should take the stairs more often. Its a simple way to improve our health thats available to almost everyone no matter where they are. But, just like our medications, we dont do what were supposed to do. By simply changing the way we encourage people to change their behavior, we can create something different, something that might just work.
Digital technology makes it really simple to create fun and engaging gamesgames that can teach us to change our behavior while were doing something we enjoy. When I mentioned earlier that I had an idea that wasnt on the list above and hadnt been tried before, I wasnt being totally honest. You see, someone has taken this approach in healthcareand it worked. I actually wrote about this a long time ago in a post called Gaming To Save Healthcare Marketing.
The greatest example of fun leading to a behavior change in healthcare is Re-Mission. This game was created to help kids fighting various cancers. Its essentially a first-person shooter-type game, but youre battling the disease.
Well, isnt that nice. They created a game for kids fighting cancer to help them pass the time during treatment. Right? No. This game was designed to improve outcomes. In fact, the company behind this game, Hope Lab, conducted a randomized trial to test the games effectiveness. Half played Re-Mission and half another video game. The results were published in the journal Pediatrics. Here are some high points:
Yes, you read that right: Adherence to at-home medication was significantly improved. How did Re-Mission manage to do this? The game is fun and, if we follow Tobys logic, we learn by playing. Thats just what happened here. These kids learned about their disease and its treatment by playing. Not only that, they learned by playing something they enjoyed.
Perhaps this is the real key to improving compliance. Its not about creating fear-laced predictions. Not about creating nagging reminders. Not about creating tedious tracking tools. And not about spying on people. These are the things we do in most of our compliance programs today. They arent working like we need them to, so isnt it time to find something different?
PS: There are a couple more experiments beyond the stairs that Volkswagon tried. All with the idea of fun, check out what else they managed to do:
Jonathan is Director of Business Development for Bridge Worldwide, a leading digital and relationship marketing agency, and regularly writes about pharma marketing on his blog Dose of Digital. Feel free to send him a tweet to @jonmrich.
Dr Vivienne van de Walle offers 9 steps pharma companies can take to improve clinical trials based...
But just when is access really early, and what are the options for companies to consider in 2015?
In the last column, I talked about what works in adherence and drew some parallels between pharma...